Skip to main content
. 2016 Dec 19;7:608. doi: 10.3389/fimmu.2016.00608

Table 6.

Incidence of public CDR3 sequences.

CDR3 (amino acid) RE blood (%) FCD/TSC blood (%) Normal blood (%)
CASSGGSTDTQYF 43 14 69
CASSVAYEQYF 14 14 43
CASSPDRVETQYF 0 7 38
CASSTSSTDTQYF 0 14 25
CASSSDGNTGELFF 0 0 21
CASSLRGTGNTEAFF 7 0 17
CAISESNYGYTF 7 7 16
CASSLSSFQETQYF 0 0 6
CASTLQMNTEAFF 7 0 5
CASSQDEGDEQYF 0 7 2
CASAEEWSSYNSPLHF 0 7 2
CASSTPGQGIGGYTF 0 0 2
CASAVAYEQYF 0 0 1
CASSLLVVESELHTGELFF 7 0 0
CASSKTSGPDNEQFF 7 0 0
CASTLLRDTDTQYF 7 0 0
CASGPGGPSTGELFF 7 0 0
CASSQDPQGALNEQFF 7 0 0
CASSYRPESYNEQFF 7 0 0
CASGRGTSGPTGELFF 7 0 0
CASSVDHRAGKPYEQYF 7 0 0
CATSVTTGGYTEAFF 7 0 0
CASSLRNYDDRVGYYEQYF 7 0 0
CASSLGTGDRSNQPQHF 7 0 0
CASGYEGGSTEAFF 7 0 0
CASQLGAATGYTF 7 0 0
CVSSPGVPFTRFNTEAFF 0 0 0
CASSLNPDRGIYEQFF 0 0 0
CASSDSRGNIQYF 0 0 0
CASSQDTPGQFYEQYF 0 0 0
CASSLQDRGPGGEQYV 0 0 0

CDR3, third complementarity region; RE, Rasmussen encephalitis; FCD, focal cortical dysplasia; TSC, tuberous sclerosis complex.